RSC BMCS Inflammation 2010
18 November 2010, GlaxoSmithKline, Stevenage
First Circular and Application Form
APPLICATION FORM
Please note that a late application fee applies after 18 October 2010.
This form should be completed clearly and returned with your remittance to: Conference Secretariat,
Maggi Churchouse, 3 East Barn, Market Weston Road, Thelnetham, Diss IP22 1JJ, UK
Fax: +44 (0)1359 221004, e-mail: [email protected]
Title (Prof, Dr, etc): …………………………… First Name: ……………………………………………………………………………………………
Last (Family) Name:……………………………………………………………………………….................................................................…
Job Title: ……………………………………………………………………………......................................................................................
Organisation: …………………………………………………………………………………………………………………………………………………………
Address: ……………………………………………………………………………………………………………………………….................................…
…………………………………………………………………………………………………………………………………………………………………………………
Postcode: ……………………………
E-mail (to be included in List of Participants): ……………………………………………………………………………………………………
Telephone(for contact by us): …………………………………………………………………………………………………………………………………
Special needs: please inform us any dietary requirements, access or other facilities required
………………………………………………………………………………………………………………………………………………………………………………
Registration Fees
Please tick as appropriate.
Up to 1 Sept
Members
£80
Non-members
£140
Student members
£40
Non-member students
£70
Add late booking fee for registration payments received by the Secretariat after 18 October
1 Sept to 18 Oct
£92
£161
£46
£80
£30
Payment Methods
1.
2.
3.
Cheque
I enclose a cheque payable to Maggi Churchouse Events for £ ……………
Bank Transfer
Payments may be made by BACS - please contact Conference Secretariat for details. All charges must
be paid by the sender. Please include the delegate name as the reference in the bank instruction and
send a copy with the application form.
Card
Card payments may be made online at www.maggichurchouseevents.co.uk/bmcs
DATA PROTECTION: The information you supply will be used for the administration of the meeting. A list of
participants’ names and e-mail addresses will be distributed at the conference. If you DO NOT wish your address
to be included, please tick the box.
Signed ………………………………………………………………………………………………………………………… Date ……………………………
Inflammation 2010
Thursday 18th November 2010
GlaxoSmithKline, Stevenage, UK
P
W
·
Introduction and Programme
a
t
·
·
·
·
R
·
·
·
·
·
·
·
F
·
M
·
·
·
·
·
e
D
m
U
F
R
i
R
f
F
T
P
r
·
·
·
e
c
r
o
e
u
n
g
l
y
b
l
a
d
f
r
t
o
l
i
f
r
t
f
t
r
a
i
P
v
l
i
t
o
s
o
d
i
r
m
u
p
p
e
l
c
d
v
u
l
a
m
y
i
c
t
u
i
e
e
g
n
t
d
r
t
i
m
e
o
o
h
n
o
e
s
g
i
o
e
v
v
n
f
o
i
l
t
e
i
n
l
g
f
d
c
i
a
e
s
u
e
m
h
c
o
a
m
r
p
t
f
q
d
o
o
e
l
a
r
l
a
a
e
t
t
i
s
o
l
u
n
a
i
e
a
d
H
e
t
A
s
t
r
h
C
s
a
i
o
g
e
P
C
n
h
g
o
r
r
i
e
o
r
f
r
g
s
a
l
m
m
e
o
a
i
o
e
f
e
w
m
f
m
k
n
t
i
n
T
a
o
e
w
h
p
c
o
i
t
r
n
o
i
a
?
k
a
r
i
c
l
Q
n
s
i
n
M
g
d
R
i
c
A
a
f
t
r
r
n
i
r
u
e
l
e
s
i
f
i
c
a
n
c
e
a
s
s
a
n
i
r
s
m
t
:
e
a
r
w
w
y
h
o
i
n
r
d
a
t
m
i
c
r
o
b
i
o
l
o
g
i
c
a
l
k
i
c
a
t
o
r
s
,
i
n
c
l
u
d
i
n
g
n
o
n
l
s
i
t
d
i
k
e
t
d
t
e
i
i
a
o
t
f
t
t
i
m
e
e
l
r
l
b
t
a
a
p
y
n
v
w
m
a
m
y
h
r
o
d
[
s
i
:
y
n
r
s
l
s
a
o
e
a
r
a
s
a
s
u
e
w
n
c
s
Q
e
h
i
n
r
m
a
u
d
i
c
e
a
r
n
t
e
d
e
o
f
f
i
n
e
s
o
n
t
W
r
o
m
i
o
r
v
e
r
H
u
g
f
e
v
t
r
t
n
i
t
h
e
s
e
b
a
c
t
e
r
i
a
a
s
]
n
a
a
o
d
e
O
l
i
o
n
d
o
w
U
n
s
S
i
E
t
h
P
i
n
A
t
c
h
r
e
i
t
e
r
i
a
?
?
w
e
d
i
p
r
d
i
t
n
r
c
e
:
l
o
l
m
r
t
e
y
r
t
?
r
g
a
:
l
d
a
t
h
r
e
u
?
s
p
w
e
o
o
r
c
o
i
a
k
t
f
t
l
s
n
i
r
:
a
a
a
a
h
n
e
d
o
s
t
l
u
n
o
f
r
w
s
s
u
n
l
o
-
o
o
q
i
i
f
o
t
g
a
g
r
s
t
t
a
p
e
r
f
o
i
h
-
c
s
s
o
t
i
h
m
o
d
r
i
m
d
t
o
t
o
a
e
w
a
n
a
c
c
n
g
c
r
d
f
i
b
t
n
o
?
a
t
s
e
l
a
i
c
r
a
a
s
o
n
s
d
a
a
c
g
t
s
c
r
i
i
t
e
l
s
i
i
a
:
n
W
e
d
r
a
d
n
f
d
d
e
e
i
a
l
a
h
c
n
a
o
n
t
a
t
l
o
i
t
e
a
e
o
n
n
a
f
u
e
c
n
a
e
i
o
g
p
a
a
t
a
o
i
f
s
n
c
r
c
c
s
g
:
i
i
r
i
e
h
e
e
e
i
g
h
l
g
a
o
t
c
w
h
a
s
u
t
m
t
o
t
s
n
o
s
n
d
c
a
u
r
s
a
e
f
d
g
i
l
e
a
n
t
b
r
a
c
a
:
w
r
u
a
c
o
a
?
Information
Information
r
o
t
i
a
n
k
l
v
m
n
a
t
f
n
o
i
n
s
e
)
s
v
i
l
n
m
t
r
i
e
a
i
s
a
o
r
:
w
f
s
d
:
o
l
k
c
t
h
s
o
r
g
g
a
s
i
s
t
e
f
r
p
t
o
n
i
i
d
l
n
o
s
y
i
a
i
n
c
i
d
n
f
a
s
f
e
p
i
r
c
H
m
l
a
e
n
o
o
r
e
t
u
c
t
d
e
o
o
i
k
l
r
i
y
e
s
a
t
c
n
h
:
.
h
c
u
l
a
h
l
m
i
t
s
n
v
s
t
c
e
n
s
s
d
c
e
f
n
a
k
i
g
e
a
r
d
a
e
t
o
f
s
e
t
o
c
e
r
l
a
r
m
e
m
h
i
o
e
s
n
:
c
o
l
w
h
r
i
s
:
?
o
s
h
t
t
n
s
e
o
i
i
n
i
a
r
s
m
a
a
h
r
i
m
n
r
r
y
w
f
d
o
o
p
e
d
a
r
e
a
s
i
s
i
u
S
o
c
e
n
a
i
d
l
r
r
s
r
i
y
h
c
S
d
r
o
m
t
s
d
u
g
r
o
c
o
t
o
a
t
o
o
m
t
i
u
r
o
n
o
c
t
r
d
a
n
h
o
g
r
q
t
a
a
p
r
n
c
i
e
s
a
l
o
f
a
e
f
a
t
l
o
a
t
t
c
s
t
y
e
n
o
e
t
c
o
c
i
o
a
d
m
i
n
e
a
i
n
i
d
t
r
l
n
a
y
i
r
c
s
e
h
d
n
i
s
t
g
i
d
e
t
t
p
w
o
a
i
p
d
u
a
n
d
n
s
t
n
i
y
m
b
p
W
i
i
i
i
t
o
m
s
(
g
n
n
w
l
n
l
l
o
e
e
w
s
e
p
e
a
d
o
r
d
y
r
d
e
i
r
i
l
r
a
o
i
r
d
i
e
e
n
o
l
t
l
i
c
e
c
s
a
p
e
p
i
o
a
C
a
u
t
v
p
i
y
o
t
a
o
a
c
v
e
e
a
p
s
h
h
m
r
c
e
e
i
g
a
a
l
p
i
g
c
p
r
s
e
e
r
e
h
s
m
k
n
n
i
e
t
e
a
h
e
h
N
t
T
I
T
I
i
o
e
a
d
T
t
S
r
s
a
n
r
F
D
R
M
H
E
A
p
o
w
a
o
h
a
w
t
i
f
t
a
a
s
e
e
r
c
s
a
:
i
l
s
b
t
a
c
h
e
t
r
e
r
e
i
a
a
v
h
a
a
v
l
e
u
e
?
a
p
a
r
t
t
o
y
t
h
e
i
r
p
o
t
e
n
t
i
a
l
w
h
e
n
a
s
s
e
s
s
i
n
?
m
l
y
c
v
i
f
c
o
o
a
r
h
r
i
o
m
l
t
u
s
m
a
n
r
l
o
e
l
s
a
n
r
g
a
o
k
e
n
u
e
r
?
r
c
e
s
s
d
d
a
t
a
q
u
a
l
i
t
y
Introduction
Venue
The objective of the meeting is to bring together scientists with an interest in
inflammation research, and to encourage the communication and discussion
of recent advances and results – ranging from early research findings to
clinical data. Attendees will hear from world-class speakers who will be
discussing new therapeutic approaches for the treatment of the wide range
of serious diseases driven by underlying inflammatory processes.
Stevenage is convenient for travel by road or rail. Located on the A1, there is parking
Programme
09.00
09.25
09.30
10.30
11.10
11.40
12.20
13.00
14.00
14.40
15.20
15.50
16.30
17.10
Registration and refreshments
Introduction
Epigenetic modulation for the future treatment of inflammatory
disease
Prof Peter Barnes, Imperial College London
Identification of potent and selective molecule inhibitors of the BET
family bromodomains demonstrate the tractability of a new class
of epigenetic targets for drug discovery
Dr Jason Witherington (Epinova DPU, GlaxoSmithKline R&D)
Refreshments
Agonism at prostacyclin receptors in the treatment of PAH
Keith J Morrison (Actelion)
Identification of ALK5 inhibitors for the treatment of PAH
Dr Duncan Shaw (Novartis Institutes for Biomedical Research)
Lunch
The discovery of novel TLR7 agonists
Roger Bonnert (AstraZeneca)
The discovery of CDP323, a novel and potent Inhibitor of the
integrins a4b1 (VLA-4) and a4b7
Julien Brown (UCB)
Refreshments
Allosteric modulation beyond GPCRs: applications to
inflammation disease targets
Dr Thibaut de Smedt (Addex Pharmaceuticals)
Generation and development of a series of MAPKAPK5 inhibitors
for the treatment of rheumatoid arthritis
Martin Andrews (Galapagos)
Close
available on site. Trains from London Kings Cross run frequently (four an hour) and
the journey time is around 30 minutes. Travel advice and directions will be sent to
registered participants.
Accommodation
We have held a number of bedrooms for this conference at the Ramada Cromwell
Hotel in Stevenage (see www.RamadaCromwellStevenage.co.uk). Studio, single and
twin rooms cost £76 for single occupancy (including breakfast and VAT). Quote
reference number 27915, and note that all rooms will be released on 17th October.
Application and Fees
Application should be made on the form overleaf before 18 October to avoid the late
fee. An early-bird discount applies before 1 September, see the application form.
Payment must be made in advance by cheque, credit card or bank transfer. In the
event of cancellation before 4 November, 80% of the fee paid will be refunded.
Refunds will not be possible after that date although substitutions are possible at any
time. In the unlikely event of cancellation of the meeting, fees paid will be refunded in
full.
The fees include attendance, abstracts, lunch and refreshments.
Acknowledgements will be sent within two weeks.
Organising Committee
Véronique Birault, GlaxoSmithKline
Catherine Leblanc, Novartis
Kathryn Bell, Cellzome
Matthew Lindon, GlaxoSmithKline
Trevor Perrior, Domainex
Secretariat
Maggi Churchouse, Conference Secretariat
Tel and fax: +44 (0)1359 221004
Email: [email protected]
Website
www.RSC.org/events
Copyright © RSC -BMCS 2010 Front cover picture copyright © Russell Kightley - www.rkm.com.au
g